Deep Track Capital, LP - 01 Oct 2025 SCHEDULE 13G Report for PALISADE BIO, INC. Common Stock, par value $0.01 per share (PALI)

Filing Manager
Deep Track Capital, LP
Reporting Manager
Deep Track Capital, LP
Security
PALISADE BIO, INC. Common Stock, par value $0.01 per share
Symbol
PALI
Shares outstanding
100,229,810 shares
Disclosed Ownership
10,012,958 shares
Ownership
10%
Form type
SCHEDULE 13G
Filing time
08 Oct 2025, 16:05:56 UTC
Date of event
01 Oct 2025
Next filing
13 Feb 2026
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"Deep Track Capital, LP disclosed 10% ownership in PALISADE BIO, INC. Common Stock, par value $0.01 per share (PALI) on 01 Oct 2025."

Quick Takeaways

  • Deep Track Capital, LP filed SCHEDULE 13G for PALISADE BIO, INC. Common Stock, par value $0.01 per share (PALI).
  • Disclosed ownership: 10%.
  • Date of event: 01 Oct 2025.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 08 Oct 2025, 16:05.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Deep Track Capital, LP 10% 10,012,958 0 10,012,958 /s/ David Kroin David Kroin, Managing Member of the General Partner of the Investment Adviser
Deep Track Biotechnology Master Fund, Ltd. 6.5% 6,509,387 0 6,509,387 /s/ David Kroin David Kroin, Director
David Kroin 10% 10,012,958 0 10,012,958 /s/ David Kroin David Kroin
Deep Track Special Opportunities Fund, LP. 3.5% 3,503,571 0 3,503,571 /s/ David Kroin David Kroin, Managing Member of the General Partner of the Investment Adviser of Deep Track Special Opportunities Fund, LP

Sponsored